Rxivist logo

Rxivist combines preprints from bioRxiv with data from Twitter to help you find the papers being discussed in your field. Currently indexing 67,545 bioRxiv papers from 297,698 authors.

Cannabis is the most frequently used illicit psychoactive substance worldwide. Life time use has been reported among 35 to 40% of adults in Denmark and the United States. Cannabis use is increasing in the population and among users around 9% become dependent. The genetic risk component is high with heritability estimates of 51 to 70%. Here we report the first genome-wide significant risk locus for cannabis use disorder (CUD, P=9.31x10-12) that replicates in an independent population (Preplication=3.27x10-3, Pmetaanalysis=9.09x10-12). The finding is based on a genome-wide association study (GWAS) of 2,387 cases and 48,985 controls followed by replication in 5,501 cases and 301,041 controls. The index SNP (rs56372821) is a strong eQTL for CHRNA2 and analyses of the genetic regulated gene expressions identified significant association of CHRNA2 expression in cerebellum with CUD. This indicates a potential therapeutic use in CUD of compounds with agonistic effect on the neuronal acetylcholine receptor alpha-2 subunit encoded by CHRNA2. At the polygenic level analyses revealed a significant decrease in the risk of CUD with increased load of variants associated with cognitive performance.

Download data

  • Downloaded 1,124 times
  • Download rankings, all-time:
    • Site-wide: 6,451 out of 67,545
    • In genomics: 1,060 out of 4,580
  • Year to date:
    • Site-wide: 7,147 out of 67,545
  • Since beginning of last month:
    • Site-wide: 8,730 out of 67,545

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide

Sign up for the Rxivist weekly newsletter! (Click here for more details.)